☆ 4.1 Article

Performance of Afirma genomic sequencing classifier and histopathological outcome in Bethesda category III thyroid nodules: Initial versus repeat fine-needle aspiration

DIAGNOSTIC CYTOPATHOLOGY (2023)

Related references

Note: Only part of the references are listed.

Article Otorhinolaryngology

Repeat Fine-Needle Aspiration With Molecular Analysis in Management of Indeterminate Thyroid Nodules

Michael R. Papazian et al.

Summary: This study analyzed the clinical outcomes of repeat fine-needle aspiration (FNA) biopsy and genomic classifier results in indeterminate thyroid nodules (ITNs). The results showed that repeat FNA helped reclassify nodules as benign, avoiding the need for diagnostic surgery. The risk of high-risk malignancy in ThyroSeq-positive nodules with repeat indeterminate cytology was low.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2023)

Add to Collection

Article Oncology

Risk stratification of cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat FNA: Implications for molecular testing and surveillance

Elizabeth A. A. Hall et al.

Summary: This study evaluates the utility of molecular testing and estimates the risk of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) and cancer among patients with cytologically indeterminate thyroid nodules with nondiagnostic or benign cytology on repeat fine-needle aspiration. The results show that nodules with nondiagnostic cytology on repeat fine-needle aspiration have a low but nonnegligible risk of NIFTP and/or cancer.

CANCER CYTOPATHOLOGY (2023)

Add to Collection

Review Otorhinolaryngology

Diagnostic performance of the second-generation molecular tests in the assessment of indeterminate thyroid nodules: A systematic review and meta-analysis

Esther Lee et al.

Summary: The objective of this systematic review and meta-analysis was to evaluate the diagnostic performance of second-generation molecular tests in diagnosing thyroid nodules with indeterminate fine-needle aspiration biopsy results. The pooled data showed that both Afirma GSC and Thyroseq v3 had high sensitivity and negative predictive value, indicating their potential to rule out malignancy in thyroid nodules.

AMERICAN JOURNAL OF OTOLARYNGOLOGY (2022)

Add to Collection

Review Oncology

Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada

Mohannad Rajab et al.

Summary: The identification and molecular testing of thyroid cancer markers are important in assisting clinical decision-making, helping patients avoid unnecessary surgeries, and optimizing treatment options in the early stages.

CANCERS (2022)

Add to Collection

Review Oncology

Diagnostic performances of the Afirma gene sequencing classifier in comparison with the gene expression classifier: A meta-analysis

Huy Gia Vuong et al.

Summary: Compared with GEC, GSC showed higher BCR, lower RR, and higher ROM. The BCR of Hurthle cell-predominant nodules was significantly elevated, while the specificity and PPV of Afirma GSC were significantly improved, maintaining high sensitivity and NPV as well.

CANCER CYTOPATHOLOGY (2021)

Add to Collection

Article Cell Biology

Comparison of Afirma Gene Expression Classifier with Gene Sequencing Classifier in indeterminate thyroid nodules: A single-institutional experience

Yipeng Geng et al.

Summary: Our study illustrates that GSC outperforms GEC in test performance, with a higher rate of benign classification and a significant reduction in unnecessary surgeries.

CYTOPATHOLOGY (2021)

Add to Collection

Article Pathology

Cytological Sub-Classification of Atypia of Undetermined Significance May Predict Malignancy Risk in Thyroid Nodules

Abdulghani Elomami et al.

Summary: The study found that repeat FNA in Bethesda III category thyroid nodules provided definitive diagnostic utility in 50% of cases, with 80% of malignant cases demonstrating nuclear atypia. Risk stratification based on clinical parameters is crucial for predicting malignancy and proper management.

ACTA CYTOLOGICA (2021)

Add to Collection

Article Endocrinology & Metabolism

Repeat Fine Needle Aspiration Cytology Refines the Selection of Thyroid Nodules for Afirma Gene Expression Classifier Testing

Michiya Nishino et al.

Summary: Repeat FNA cytology can guide the selection of indeterminate thyroid nodules for molecular testing, reducing unnecessary surgical risks for benign nodules while only missing a few low-risk tumors.

THYROID (2021)

Add to Collection

Article Endocrinology & Metabolism

Single Institution Experience with Afirma and Thyroseq Testing in Indeterminate Thyroid Nodules

Michele Gortakowski et al.

Summary: Thyroid nodules are commonly found on examinations, with up to 15% having indeterminate cytology. Molecular testing is helpful in identifying high-risk nodules, and the GSC has shown to be more likely to classify cytologically indeterminate nodules as benign with higher specificity and positive predictive value compared to GEC.

THYROID (2021)

Add to Collection

Article Medical Laboratory Technology

Performance of Afirma genomic sequencing classifier vs gene expression classifier in Bethesda category III thyroid nodules: An institutional experience

Lin Zhang et al.

Summary: The study compared the diagnostic performance and clinical management impact of GSC and GEC, finding that GSC significantly improved BCR, RSS, RHM, and diagnostic performance, thereby aiding in avoiding unnecessary surgery for AUS/FLUS thyroid nodules.

DIAGNOSTIC CYTOPATHOLOGY (2021)

Add to Collection

Article Medical Laboratory Technology

Malignancy outcomes and the impact of repeat fine needle aspiration of thyroid nodules with Bethesda category III cytology: A multicenter experience

Derya Koseoglu et al.

Summary: This study investigated the management and outcomes of 333 patients with Bethesda III category thyroid nodules in three tertiary medical centers in Turkey, showing a higher malignancy rate of 48.65% among patients receiving thyroidectomy compared to the traditional rate of 5%-15%. Repeat FNAs were shown to decrease the rate of unnecessary surgery performed for benign lesions by increasing the rate of malignancy detection.

DIAGNOSTIC CYTOPATHOLOGY (2021)

Add to Collection

Article

Molecular testing results as a quality metric for evaluating cytopathologists’ utilization of the atypia of undetermined significance category for thyroid nodule fine-needle aspirations

Paul A. VanderLaan et al.

Journal of the American Society of Cytopathology (2021)

Add to Collection

Article Endocrinology & Metabolism

Comparison of Afirma GEC and GSC to Nodules Without Molecular Testing in Cytologically Indeterminate Thyroid Nodules

Preethi Polavarapu et al.

Summary: This study retrospectively analyzed cytologically indeterminate thyroid nodules and found that the implementation of the Afirma Gene Expression Classifier (GEC) did not affect surgical or malignancy rates, while the Genomic Sequencing Classifier (GSC) resulted in significantly lower surgical rates and higher malignancy rates. Factors associated with the decision to undergo molecular testing were identified, providing insights into the real-world use of molecular markers in indeterminate thyroid nodules.

JOURNAL OF THE ENDOCRINE SOCIETY (2021)

Add to Collection

Review Pathology

Role of Ancillary Techniques in Thyroid Cytology Specimens

Michiya Nishino et al.

ACTA CYTOLOGICA (2020)

Add to Collection

Article Endocrinology & Metabolism

Real-world Comparison of Afirma GEC and GSC for the Assessment of Cytologically Indeterminate Thyroid Nodules

Vicente T. San Martin et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Add to Collection

Article Endocrinology & Metabolism

Independent Comparison of the Afirma Genomic Sequencing Classifier and Gene Expression Classifier for Cytologically Indeterminate Thyroid Nodules

Trevor E. Angell et al.

THYROID (2019)

Add to Collection

Article Endocrinology & Metabolism

Afirma Gene Sequencing Classifier Compared with Gene Expression Classifier in Indeterminate Thyroid Nodules

Mayumi Endo et al.

THYROID (2019)

Add to Collection

Article Oncology

Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience

Shuanzeng Wei et al.

CANCER CYTOPATHOLOGY (2019)

Add to Collection

Article Endocrinology & Metabolism

The 2017 Bethesda System for Reporting Thyroid Cytopathology

Edmund S. Cibas et al.

THYROID (2017)

Add to Collection

Article Oncology

Qualifiers of Atypia in the Cytologic Diagnosis of Thyroid Nodules Are Associated With Different Afirma Gene Expression Classifier Results and Clinical Outcomes

Sylvan C. Baca et al.

CANCER CYTOPATHOLOGY (2017)

Add to Collection

Article Endocrinology & Metabolism

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer

Bryan R. Haugen et al.

THYROID (2016)

Add to Collection

Article Oncology

Nomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma A Paradigm Shift to Reduce Overtreatment of Indolent Tumors

Yuri E. Nikiforov et al.

JAMA ONCOLOGY (2016)

Add to Collection

Article Medicine, General & Internal

Thyroid Nodules

Geanina Popoveniuc et al.

MEDICAL CLINICS OF NORTH AMERICA (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.